06.05.2017
Prevent & Delay
$1,349,653.00
48 months
Preservation of pancreatic beta cells using antigen-specific tolerizing immunotherapy in children with type 1 diabetes
In partnership with JDRF Australia, funds support a project at the University of Queensland that will develop and clinically test a disease-specific drug to delay type 1 diabetes.